Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis

The medical application of cannabidiol (CBD) has been gathering increasing attention in recent years. This non-psychotropic cannabis-derived compound possesses antiepileptic, antipsychotic, anti-inflammatory and anxiolytic properties. Recent studies report that it also exerts antineoplastic effects...

Full description

Bibliographic Details
Main Authors: Paweł Marzęda, Paula Wróblewska-Łuczka, Małgorzata Drozd, Magdalena Florek-Łuszczki, Katarzyna Załuska-Ogryzek, Jarogniew J. Łuszczki
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/12/6752
_version_ 1797486340116316160
author Paweł Marzęda
Paula Wróblewska-Łuczka
Małgorzata Drozd
Magdalena Florek-Łuszczki
Katarzyna Załuska-Ogryzek
Jarogniew J. Łuszczki
author_facet Paweł Marzęda
Paula Wróblewska-Łuczka
Małgorzata Drozd
Magdalena Florek-Łuszczki
Katarzyna Załuska-Ogryzek
Jarogniew J. Łuszczki
author_sort Paweł Marzęda
collection DOAJ
description The medical application of cannabidiol (CBD) has been gathering increasing attention in recent years. This non-psychotropic cannabis-derived compound possesses antiepileptic, antipsychotic, anti-inflammatory and anxiolytic properties. Recent studies report that it also exerts antineoplastic effects in multiple types of cancers, including melanoma. In this in vitro study we tried to reveal the anticancer properties of CBD in malignant melanoma cell lines (SK-MEL 28, A375, FM55P and FM55M2) administered alone, as well as in combination with mitoxantrone (MTX) or cisplatin (CDDP). The effects of CBD on the viability of melanoma cells were measured by the MTT assay; cytotoxicity was determined in the LDH test and proliferation in the BrdU test. Moreover, the safety of CBD was tested in human keratinocytes (HaCaT) in LDH and MTT tests. Results indicate that CBD reduces the viability and proliferation of melanoma-malignant cells and exerts additive interactions with MTX. Unfortunately, CBD produced antagonistic interaction when combined with CDDP. CBD does not cause significant cytotoxicity in HaCaT cell line. In conclusion, CBD may be considered as a part of melanoma multi-drug therapy when combined with MTX. A special attention should be paid to the combination of CBD with CDDP due to the antagonistic interaction observed in the studied malignant melanoma cell lines.
first_indexed 2024-03-09T23:32:47Z
format Article
id doaj.art-0f1c22e8488e49008ffcb4e832701d91
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T23:32:47Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-0f1c22e8488e49008ffcb4e832701d912023-11-23T17:06:12ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-06-012312675210.3390/ijms23126752Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic AnalysisPaweł Marzęda0Paula Wróblewska-Łuczka1Małgorzata Drozd2Magdalena Florek-Łuszczki3Katarzyna Załuska-Ogryzek4Jarogniew J. Łuszczki5Department of Pathophysiology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Pathophysiology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Pathophysiology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Medical Anthropology, Institute of Rural Health, 20-950 Lublin, PolandDepartment of Pathophysiology, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Pathophysiology, Medical University of Lublin, 20-090 Lublin, PolandThe medical application of cannabidiol (CBD) has been gathering increasing attention in recent years. This non-psychotropic cannabis-derived compound possesses antiepileptic, antipsychotic, anti-inflammatory and anxiolytic properties. Recent studies report that it also exerts antineoplastic effects in multiple types of cancers, including melanoma. In this in vitro study we tried to reveal the anticancer properties of CBD in malignant melanoma cell lines (SK-MEL 28, A375, FM55P and FM55M2) administered alone, as well as in combination with mitoxantrone (MTX) or cisplatin (CDDP). The effects of CBD on the viability of melanoma cells were measured by the MTT assay; cytotoxicity was determined in the LDH test and proliferation in the BrdU test. Moreover, the safety of CBD was tested in human keratinocytes (HaCaT) in LDH and MTT tests. Results indicate that CBD reduces the viability and proliferation of melanoma-malignant cells and exerts additive interactions with MTX. Unfortunately, CBD produced antagonistic interaction when combined with CDDP. CBD does not cause significant cytotoxicity in HaCaT cell line. In conclusion, CBD may be considered as a part of melanoma multi-drug therapy when combined with MTX. A special attention should be paid to the combination of CBD with CDDP due to the antagonistic interaction observed in the studied malignant melanoma cell lines.https://www.mdpi.com/1422-0067/23/12/6752cannabinoidscannabidiolmelanomain vitro studydrug interactions
spellingShingle Paweł Marzęda
Paula Wróblewska-Łuczka
Małgorzata Drozd
Magdalena Florek-Łuszczki
Katarzyna Załuska-Ogryzek
Jarogniew J. Łuszczki
Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis
International Journal of Molecular Sciences
cannabinoids
cannabidiol
melanoma
in vitro study
drug interactions
title Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis
title_full Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis
title_fullStr Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis
title_full_unstemmed Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis
title_short Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis
title_sort cannabidiol interacts antagonistically with cisplatin and additively with mitoxantrone in various melanoma cell lines an isobolographic analysis
topic cannabinoids
cannabidiol
melanoma
in vitro study
drug interactions
url https://www.mdpi.com/1422-0067/23/12/6752
work_keys_str_mv AT pawełmarzeda cannabidiolinteractsantagonisticallywithcisplatinandadditivelywithmitoxantroneinvariousmelanomacelllinesanisobolographicanalysis
AT paulawroblewskałuczka cannabidiolinteractsantagonisticallywithcisplatinandadditivelywithmitoxantroneinvariousmelanomacelllinesanisobolographicanalysis
AT małgorzatadrozd cannabidiolinteractsantagonisticallywithcisplatinandadditivelywithmitoxantroneinvariousmelanomacelllinesanisobolographicanalysis
AT magdalenaflorekłuszczki cannabidiolinteractsantagonisticallywithcisplatinandadditivelywithmitoxantroneinvariousmelanomacelllinesanisobolographicanalysis
AT katarzynazałuskaogryzek cannabidiolinteractsantagonisticallywithcisplatinandadditivelywithmitoxantroneinvariousmelanomacelllinesanisobolographicanalysis
AT jarogniewjłuszczki cannabidiolinteractsantagonisticallywithcisplatinandadditivelywithmitoxantroneinvariousmelanomacelllinesanisobolographicanalysis